NFCR Shines a Spotlight to Cure the Rare Vision Loss Associated with Some Cancers
[vc_row][vc_column][vc_single_image image="57729" img_size="full" alignment="center"][vc_column_text]Cancer-Associated Retinopathy (CAR) may occur when lung, breast, or other cancers form antibodies that attack and destroy the retina's vision cells. No therapy is available to replace the cells; patients will have vision loss or even blindness. At our 2022 Global Summit and...